Clinical Trial Update: Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study of Tapinarof Cream 1% in adults with extensive plaque psoriasis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tapinarof Cream 1% (tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-05-06